REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 26th, 2019 • AbbVie Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT dated November 21, 2019 (this “Agreement”) is entered into by and among AbbVie Inc., a Delaware corporation (the “Company”), and, upon execution of the joinder agreement referred to below, each Guarantor (as defined below), and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Barclays Capital Inc., as representatives (collectively, the “Representatives”) of the initial purchasers listed in Schedule I to the Purchase Agreement (as defined below) (the “Initial Purchasers”). The agreements of each Guarantor under this Agreement shall not become effective unless and until such Guarantor executes a joinder agreement to this Agreement, which joinder agreement shall be substantially in the form attached as Exhibit A to this Agreement (the “Joinder Agreement”), at which time such agreements shall become effective pursuant to the terms of the Joinder Agreement (and until such time, such Guarantor shall not be a party to this Agreement or make any representa
